Dake Benjamin T's Form 4 filing
Jade Biosciences, Inc. (JBIO) · filed Nov 14, 2022
- Accession no.
- 0001415889-22-011356
- Filed
- Nov 14, 2022
- Trade date
- Nov 9-11, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 3 derivative transactions. Open-market sales total $415.2K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dake Benjamin TCIK 0001869248 | Officer (SEE REMARKS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2022 | Common Stock | MOption exerciseAcquired | +14,000 | $2.14 | +$29,960 | 14,000 | Direct | |
| Nov 9, 2022 | Common Stock | SSaleDisposed | −14,000 | $17.91F2 | −$250,740 | 0 | Direct | |
| Nov 10, 2022 | Common Stock | MOption exerciseAcquired | +1,800 | $2.14 | +$3,852 | 1,800 | Direct | |
| Nov 10, 2022 | Common Stock | SSaleDisposed | −1,800 | $20.10F3 | −$36,180 | 0 | Direct | |
| Nov 11, 2022 | Common Stock | MOption exerciseAcquired | +6,198 | $2.14 | +$13,263.72 | 6,198 | Direct | |
| Nov 11, 2022 | Common Stock | SSaleDisposed | −4,452 | $20.39F4 | −$90,776.28 | 1,746 | Direct | |
| Nov 11, 2022 | Common Stock | SSaleDisposed | −1,625 | $21.41F5 | −$34,791.25 | 121 | Direct | |
| Nov 11, 2022 | Common Stock | SSaleDisposed | −121 | $22.20F6 | −$2,686.2 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2022 | Common Stock | MOption exerciseDisposed | −14,000 | $0.00 | $0 | 262,598 | Direct | |
| Nov 10, 2022 | Common Stock | MOption exerciseDisposed | −1,800 | $0.00 | $0 | 260,798 | Direct | |
| Nov 11, 2022 | Common Stock | MOption exerciseDisposed | −6,198 | $0.00 | $0 | 254,600 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.49 to $18.26, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.02 to $20.406, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.965, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.02 to $21.96, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.16 to $22.205, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
Remarks
Officer Title: President, Chief Operating Officer and Secretary